S.216 (Act 165)

An act relating to prescription drugs

Sponsors: Sen. Kevin Mullin,

Last Recorded Action: 5/6/2016 - Signed by Governor on June 2, 2016

Committee Activity - Meeting Full List

2015 - 2016 Legislative Session

Wednesday, January 13, 2016

Committee(s):

Senate Committee on Finance,

4:35 PM

S.216 - An act relating to prescription drugs

Sen. Kevin Mullin

Tuesday, February 16, 2016

Committee(s):

Senate Committee on Finance,

3:00 PM

S.216 - An act relating to prescription drugs

Jill Sudhoff-Guerin, Government Relations Director, American Cancer Society, Vermont
Jennifer Carbee, Legislative Counsel, Office of Legislative Council

Wednesday, February 17, 2016

Committee(s):

Senate Committee on Finance,

3:15 PM

S.216 - An act relating to prescription drugs

Maya Thompson, Lead Case Manager, Health Assistance Program of the Free Clinics
Brian Murphy, Pharmacy Program Director, Blue Cross/Blue Shield of Vermont
Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
Charles Storrow, Lobbyist, Express Scripts, Inc.
Margaret Laggis, Lobbyist, American health Insurance Plan
Jennifer Carbee, Legislative Counsel, Office of Legislative Council

Thursday, February 18, 2016

Committee(s):

Senate Committee on Finance,

2:00 PM

S.216 - An act relating to prescription drugs

Robin Lunge, Director of Health Care Reform, Agency of Administration
Jennifer Carbee, Legislative Counsel, Office of Legislative Council

Tuesday, February 23, 2016

Committee(s):

Senate Committee on Finance,

1:30 PM

S.216 - An act relating to prescription drugs

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nancy Hogue, Director of Pharmacy Services, Department of Vermont Health Access (DVHA)
Susan Barrett, Executive Director, Green Mountain Care Board
Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
Margaret Laggis, Lobbyist, American health Insurance Plan
Cory Gustafson, Director, Government and Public Relations, Blue Cross/Blue Shield of Vermont
Madeleine Mongan, Vice-President, Vermont Medical Society
Jeff Hochberg, President, Vermont Retail Druggists Association
Jamie Feehan, Lobbyist, CVS/Caremark

Wednesday, March 9, 2016

Committee(s):

Senate Committee on Finance,

3:00 PM

S.216 - An act relating to prescription drugs

Mark-up

Devon Green, Special Counsel, Agency of Administration
Marguerite Monet, Social Worker, AIDS Project of Southern Vermont
Jill Sudhoff-Guerin, Government Relations Director, American Cancer Society, Vermont
Charles Storrow, Lobbyist, Express Scripts, Inc.

Friday, March 11, 2016

Committee(s):

Senate Committee on Finance,

4:20 PM

S.216 - An act relating to prescription drugs

Possible Vote

Jennifer Carbee, Legislative Counsel, Office of Legislative Council

Wednesday, March 23, 2016

Committee(s):

House Committee on Health Care,

10:00 AM

S.216 - An act relating to prescription drugs

Jennifer Carbee, Legislative Counsel, Office of Legislative Council

Friday, April 1, 2016

Committee(s):

House Committee on Health Care,

11:00 AM

S.216 - An act relating to prescription drugs

11:00 or after the Floor.

Devon Green, Special Counsel for Health Care Reform, Agency of Administration
Jill Sudhoff-Guerin, Government Relations Director, American Cancer Society, Vermont
Cory Gustafson, Director, Government and Public Relations, Blue Cross/Blue Shield of Vermont

Tuesday, April 12, 2016

Committee(s):

House Committee on Health Care,

2:30 PM

S.216 - An act relating to prescription drugs

Brian Murphy, Pharmacy Program Director, Blue Cross/Blue Shield of Vermont
Sen. Kevin Mullin, Bill Sponsor
Sen. Michael Sirotkin
Marguerite Monet, Social Worker, AIDS Project of Southern Vermont
Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
Margaret Laggis, Lobbyist, America's Health Insurance Plans
Wendy Morgan, Assistant Attorney General, Attorney General's Office
Jennifer Carbee, Legislative Counsel, Office of Legislative Council

Wednesday, April 20, 2016

Committee(s):

House Committee on Health Care,

9:00 AM

S.216 - An act relating to prescription drugs

Nancy Hogue, Director of Pharmacy Services, Department of Vermont Health Access (DVHA)
Jennifer Carbee, Legislative Counsel, Office of Legislative Council

Thursday, April 21, 2016

Committee(s):

House Committee on Health Care,

9:00 AM

S.216 - An act relating to prescription drugs

Including amendment re bronze plans. Discussion included H.866.

Devon Green, Special Counsel for Health Care Reform, Agency of Administration
Virginia Renfrew, Lobbyist, AIDS Services Organizations and American Cancer Society
Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
Trinka Kerr, Chief Health Care Advocate, Office of the Health Care Advocate
Cory Gustafson, Director, Government and Public Relations, Blue Cross/Blue Shield of Vermont

11:00 AM

S.216 - An act relating to prescription drugs

Discussion, including 340B program

Devon Green, Special Counsel for Health Care Reform, Agency of Administration
Sharon Winn, Director, Vermont Public Policy, Bi-State Primary Care Association

2:15 PM

S.216 - An act relating to prescription drugs

Committee discussion.

Jill Olson, Vice President of Policy & Legislative Affairs, Vermont Association of Hospitals and Health Systems
Susan Barrett, JD, Executive Director, Green Mountain Care Board
Robin Lunge, Director of Health Care Reform, Agency of Administration

Friday, April 22, 2016

Committee(s):

House Committee on Health Care,

9:00 AM

S.216 - An act relating to prescription drugs

New draft; language re Rx cost disclosures; bronze plan language.
Final markup; possibly vote.

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Devon Green, Special Counsel for Health Care Reform, Agency of Administration

2:40 PM

S.216 - An act relating to prescription drugs

Final markup and vote

Jennifer Carbee, Legislative Counsel, Office of Legislative Council

Tuesday, May 3, 2016

Committee(s):

Committee of Conference,

7:30 PM

S.216 - An act relating to prescription drugs

Room 45, House Health Care

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Wendy Morgan, Assistant Attorney General, Attorney General's Office

4:30 PM

S.216 - An act relating to prescription drugs

Committee of conference, second meeting.
Room 45

Wendy Morgan, Assistant Attorney General, Attorney General's Office
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Robin Lunge, Director of Health Care Reform, Agency of Administration

9:00 AM

S.216 - An act relating to prescription drugs

Committee of conference, third meeting
Room 45

Tuesday, May 3, 2016

Committee(s):

House Committee on Health Care,

7:30 PM

S.216 - An act relating to prescription drugs

[Committee of Conference]

Wednesday, May 4, 2016

Committee(s):

Committee of Conference,

12:00 PM

S.216 - An act relating to prescription drugs

NOON MEETING IS CANCELLED

4:30 PM

S.216 - An act relating to prescription drugs

Committee of Conference

Wednesday, May 4, 2016

Committee(s):

House Committee on Health Care,

12:00 PM

S.216 - An act relating to prescription drugs

[Committee of Conference--tentative]

4:30 PM

S.216 - An act relating to prescription drugs

[Committee of Conference]

Thursday, May 5, 2016

Committee(s):

Committee of Conference,

9:00 AM

S.216 - An act relating to prescription drugs

Committee of Conference, third meeting.
Room 45

10:30 AM

S.216 - An act relating to prescription drugs

Committee of Conference

9:00 PM

S.216 - An act relating to prescription drugs

Committee of Conference; Report signed

Jennifer Carbee, Legislative Counsel, Office of Legislative Council

Thursday, May 5, 2016

Committee(s):

House Committee on Health Care,

9:00 AM

S.216 - An act relating to prescription drugs

[Committee of Conference. Room 45]

10:30 AM

S.216 - An act relating to prescription drugs

[Committee of Conference]

9:00 PM

S.216 - An act relating to prescription drugs

[Committee of Conference]